vai alle Pubblicazioni
Pubblicazioni antecedenti il 2004
Diamanti E., Souza P. C. T, Setyawati I., Bousis S., Gómez, L. M., Swier L.J.Y.M., Shams, A., Tsarenko, Stanek W. K., Jäger M., Marrink S., Slotboom D. J., Hirsch A.K. H.: Identification of inhibitors targeting the energy-coupling factor (ECF) transporters. Commun. Biol. 2023, 6, 1182.
Ropponen H-K*, Diamanti E.*, S. Johannsen, B. Illarionov, R. Hamid, M. Jaki, P.Sass, M. Fischer, J. Haupenthal, Hirsch A. K. H. “Exploring the translational gap of a novel class of Escherichia coli IspE inhibitors”, ChemMedChem 2023, e202300346.
*equal contribution.
Pasieka A., Diamanti E., Uliassi E., Bolognesi M. L. „Click chemistry” and targeted degradation: a winning combination for medicinal chemists? ChemMedChem 2023, 18, e2023004.
Gehringer M., Pape F., Pérez M. M., Barbie P., Lopez A. U., Lefranc J., Klingler F.-M., G. Hessler, T. Langer, Diamanti E.,* Matthias Schiedel* Back In-Person: The Frontiers in Medicinal Chemistry, ChemMedChem 2023 18, e2023003.
Diamanti E., Hamed M., Lacour A., Bravo P., Illarionov B., Fischer M., Rottmann M., Witschel M., Hirsch A. K. H. “Targeting the IspD enzyme in the MEP pathway: identification of a novel fragment class”, ChemMedChem, 2022, e202100679.
Drost M., Diamanti E., Fuhrmann K., A. Goes, A. Shams, J. Haupenthal, Koch M., Hirsch A.K.H., Fuhrmann G. “Bacteriomimetic liposomes improve antibiotic efficacy of a novel energy-coupling factor transporter inhibitor”, MDPI-Pharmaceutics 2022, 14(1), 4.
Bousis S., Winkler S., Haupenthal J., Fulco F., Diamanti E., Hirsch A.K. H. “An efficient way to screen inhibitors of energy-coupling factor (ECF) transporters in bacterial uptake assay”, Int. J. Mol. Sci. 2022, 23, 2637.
Kiefer A. F., Bousis S., Hamed M.M., Diamanti E., Haupenthal J. Hirsch A. K. H. “Structure-Guided Optimization of Small-Molecule Folate Uptake Inhibitors Targeting the Energy-Coupling Factor Transporters”, J. Med. Chem. 2022, 65, 13, 8869–8880.
Ropponen H-K, Bader, D. C., Diamanti E., Illarionov B., Rottmann M., Fischer M., Witschel M., Müller, R., Hirsch A. K. H. “Unravelling the Active Ingredients from a 2-Aminothiazole DMSO Stock Solution with Antimalarial Activity” ChemMedChem 2021, 16, 1‒6.
Ropponen H-K, Diamanti E., Siemens A., Illarionov B., Haupenthal J., Fischer M., Rottmann M., Witschel M., Hirsch A. K. H. “Assessment of the rules related to gaining activity against gram-negative bacteria” RSC Med. Chem., 2021, 12, 593‒601.
Bousis, S., Setyawati, I., Diamanti E., Slotboom D. J., Hirsch, A.K. H. “Energy-Coupling Factor Transporters as Novel Antimicrobial Targets” Advanced Therapeutics, 2019, 2, 1800066, 1‒17.
James C. A., Yu K. K. Q., Gilleron M., Prandi J., Yedulla V. R., Moleda Z. Z., Diamanti E., Khan M., Aggarwal, V. K., Reijneveld J. F., Reinink P., Lenz S., Emerson R.O., Scriba T.J., Souter M.N.T., Godfrey D.I., Pellicci D. G., D. Moody, B., Minnaard A.J., Seshadri C., Van Rhijn I. “CD1b tetramers identify T-cells that recognize natural and synthetic diacylated sulfoglycolipids from Mycobacterium tuberculosis” Cell Chemical Biology, 2018, 25, 1-11.
Castellani B.*, Diamanti E.*, Pizzirani D., Tardia P., Maccesi M., Realini N., Magotti P., Garau G., Bakkum T., Rivara S., Mor M., Piomelli D. “Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD)” Chem. Commun., 2017, 53, 12814-12817.
*equal contribution
Gierse R.; Redeem E.; Diamanti E.; Groves M. R.; Hirsch, A. K.H. “DXS as a target for structure-based drug design” Future Med. Chem., 2017, 11, 9, 1277-1294.
